Title:
抗コロナウイルス抗体および使用の方法
Document Type and Number:
Japanese Patent JP2023517236
Kind Code:
A
Abstract:
ＳＡＲＳ－ＣｏＶスパイクタンパク質、ＳＡＲＳ－ＣｏＶ－２スパイクタンパク質に結合する抗体、ならびにＳＡＲＳまたはＣＯＶＩＤ－１９に関連する状態を処置または予防するため、およびＳＡＲＳ－ＣｏＶまたはＳＡＲＳ－ＣｏＶ－２を検出するための、それを使用する方法。本開示は、ＣＯＶＩＤ－１９などのＳＡＲＳ－ＣｏＶおよびＳＡＲＳ－ＣｏＶ－２関連疾患の診断、モニタリングおよび処置または予防において使用され得る、方法、組成物、および製品に関する。
Inventors:
Westendorf, Kathryn
Zentelis, Stephanie
Musuraman, Kritika
jepson, kevin
Falconer, Esther
mascola, john
graham, barney
Corbett, Kismekia
Ledgerwood, Julie
One, Rinsch
Abiona, Orbucora
si, way
Kong, Win-Pui
Jean, E
Jones, Brian Edward
Foster, Denisa
Davis, Julian
Chai, Chin
Fry, Christopher Karl
Gopalrasnam, Ganapati
Hendl, Jerg
Souder, John Michael
Boyles, Jeffrey Streetman
Pastirnik, Anna
Zentelis, Stephanie
Musuraman, Kritika
jepson, kevin
Falconer, Esther
mascola, john
graham, barney
Corbett, Kismekia
Ledgerwood, Julie
One, Rinsch
Abiona, Orbucora
si, way
Kong, Win-Pui
Jean, E
Jones, Brian Edward
Foster, Denisa
Davis, Julian
Chai, Chin
Fry, Christopher Karl
Gopalrasnam, Ganapati
Hendl, Jerg
Souder, John Michael
Boyles, Jeffrey Streetman
Pastirnik, Anna
Application Number:
JP2022554815A
Publication Date:
April 24, 2023
Filing Date:
March 04, 2021
Export Citation:
Assignee:
Abselera Biologics Inc.
The United States of America, As Represented by The Secretary, Department of Health and Human Services
The United States of America, As Represented by The Secretary, Department of Health and Human Services
International Classes:
C12N15/13; A61K9/08; A61K39/395; A61K45/00; A61K47/02; A61K47/22; A61K47/26; A61K47/55; A61K47/68; A61P31/14; C07K16/10; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/08; C12Q1/70; G01N33/569
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Morishita Natsuki
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Previous Patent: Microbial consortium for the treatment of disease
Next Patent: Small start switch for automobiles with antenna
Next Patent: Small start switch for automobiles with antenna